Trusted by 100,000+ International Patients
HIPEC: Spain vs United Arab Emirates
Cost, Quality & Recovery Compared
$32000
Spain Starting Cost
$45000
United Arab Emirates Starting Cost
See how these top medical tourism destinations compare for HIPEC.
| Comparison Factor | Spain | United Arab Emirates | Winner |
|---|---|---|---|
| Average Cost (in USD) | 32000 - 94000 | 45000 - 75000 | United Arab Emirates |
| Success Rate (Min and Max) | 55% – 80% (stage and completeness dependent) | 55% – 80% | Both Equal |
| Advanced Technology | Advanced CRS + HIPEC programs with high-precision PET-CT imaging, specialised HIPEC perfusion systems, minimally invasive/robotic-assisted support, and dedicated surgical oncology ICUs | Advanced CRS + HIPEC programs in specialised oncology centres with modern perfusion systems, PET-CT imaging, and minimally invasive/robotic-assisted surgical support. | Both Equal |
| JCI Accredited Hospitals | 10+ | 15+ | United Arab Emirates |
| Visa Process | Schengen Medical Visa (7–15 working days) | Medical Visa / Tourist Visa | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth Spain and United Arab Emirates maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
Spain has internationally accredited hospitals aligned with European oncology standards, with specialised centres performing CRS + HIPEC under multidisciplinary tumour boards.
HIPEC outcomes depend on cancer type, PCI score, and completeness of cytoreduction. Spanish centres follow European oncology protocols with strong clinical outcomes in selected patients.
Healthcare is regulated by the Spanish Ministry of Health and European Medicines Agency (EMA), ensuring strict safety standards for surgical oncology and chemotherapy protocols.
Many hospitals in the UAE are accredited by the Joint Commission International (JCI) and regulated by the MOHAP, DHA, and DOH authorities.
HIPEC outcomes depend on cancer type, stage, and completeness of cytoreduction; UAE centres follow international oncology protocols and multidisciplinary tumour board approaches.
Healthcare is regulated by the Ministry of Health & Prevention (MOHAP), Dubai Health Authority (DHA), and Department of Health (DOH - Abu Dhabi), ensuring strict standards for oncology care and surgical safety.
| Quality Metric | Spain | United Arab Emirates |
|---|---|---|
Accredited Hospitals | 10+ | 15+ |
CRS + HIPEC Availability | Yes | Yes |
ICU Support Level | Advanced (tertiary/quaternary ICUs) | Advanced (tertiary & quaternary ICUs) |
Top Speciality Hospital Hubs | Madrid, Barcelona | Dubai, Abu Dhabi |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Surgical oncologists
Moderate to High Volume
Highly specialised surgical oncologists
Moderate to high procedural volume
Surgical Oncologist
Burjeel Hospital for Advanced Surgery Dubai Sharjah • 5 Years
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Leading hospitals in Spain feature advanced operating theatres, dedicated HIPEC perfusion systems, surgical oncology ICUs, robotic and minimally invasive surgery platforms, and comprehensive cancer care including pathology, molecular diagnostics, and advanced imaging systems.
Luxury healthcare experience
Top hospitals in the UAE feature advanced operating theatres, specialised HIPEC perfusion machines, surgical oncology ICUs, robotic surgery platforms, and comprehensive cancer care services, including pathology, molecular diagnostics, and advanced imaging systems.
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after HIPEC in both countries.
HIPEC is performed during cytoreductive surgery where heated chemotherapy is circulated within the abdominal cavity.
Patients are monitored in specialised ICUs post-surgery.
A local stay is recommended for wound care and early complication monitoring.
Recovery improves gradually with nutritional support, physiotherapy, and oncology follow-up care.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
HIPEC is performed alongside cytoreductive surgery to remove visible tumours and treat microscopic disease within the abdomen.
Patients require ICU monitoring immediately after surgery.
International patients are advised to stay locally for recovery and follow-up care.
Recovery improves gradually with nutrition, physiotherapy, and oncology follow-up.
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
HIPEC recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your HIPEC journey.
Higher-than-average surgical risk due to extensive cytoreduction; ICU and infection pathways are critical.
Expected due to major abdominal surgery; managed with protocols.
Possible due to nutritional depletion; requires nutrition optimisation.
Risk of bowel complications, anastomotic leak, and sepsis; it depends on the extent of surgery.
Chemo agent exposure can affect the kidneys and marrow; supportive monitoring is required.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Patients with peritoneal cancers such as colorectal cancer with peritoneal metastasis, ovarian cancer, appendiceal tumours, peritoneal mesothelioma, or pseudomyxoma peritonei who are suitable candidates for cytoreductive surgery combined with HIPEC.
Patients with peritoneal malignancies such as colorectal cancer with peritoneal spread, ovarian cancer, appendix tumours, peritoneal mesothelioma, or pseudomyxoma peritonei who are suitable candidates for cytoreductive surgery with HIPEC.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your HIPEC journey.
Doctors assess peritoneal disease using PCI scoring.
Surgeons evaluate if complete cytoreduction is achievable.
Plan ICU stay, hospital duration, and recovery support.
Budget for surgery, medications, and potential complications.
Schedule oncology follow-up and additional therapy if required.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
